Literature DB >> 17711558

Familial Mediterranean Fever in Lebanon: founder effects for different MEFV mutations.

Nadine Jalkh1, Emmanuelle Génin, Eliane Chouery, Valérie Delague, Myrna Medlej-Hashim, Charles-Antoine Idrac, André Mégarbané, Jean-Louis Serre.   

Abstract

Haplotype analysis of 376 Familial Mediterranean Fever (FMF) patients and 100 controls from Lebanon was performed using 4 microsatellite loci to study founder effects for the five most frequent mutations within the MEFV gene (M694V, M694I, V726A, M680I and E148Q). Each of these mutations was associated with a particular haplotype that was less frequent among controls, confirming that they have probably arisen from unique mutation events and that the carrier chromosomes derived from a common ancestor. The estimated ages of the most recent common ancestor for each of the 5 mutations, using the ESTIAGE program, were 7000, 8500, 15000, 23000 and 30000 years for M694V, M694I, V726A, M680I and E148Q, respectively. Varying the mutation rate at one of the markers led to younger age estimates, but the mutation E148Q remained the oldest one. Comparison of haplotype distributions among the different Lebanese religious groups confirmed that Muslim sub-populations (Shiites and Sunnites) as well as Christian ones, including Armenians who were formerly settled in the South-Eastern part of Asia Minor (Cilicia), are all derived from an ancient common ancestral population in which most of the MEFV mutations were already present with their respective associated haplotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711558     DOI: 10.1111/j.1469-1809.2007.00386.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

1.  Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis.

Authors:  Diala El Masri; Bachar Alsaayed; Jad El Masri; Bachir Zreika; Hani Chanbour; Pascale Salameh
Journal:  Rheumatol Int       Date:  2021-04-12       Impact factor: 2.631

2.  Novel Deleterious nsSNPs within MEFV Gene that Could Be Used as Diagnostic Markers to Predict Hereditary Familial Mediterranean Fever: Using Bioinformatics Analysis.

Authors:  Mujahed I Mustafa; Tebyan A Abdelhameed; Fatima A Abdelrhman; Soada A Osman; Mohamed A Hassan
Journal:  Adv Bioinformatics       Date:  2019-06-04

3.  Clinical features and disease severity of Turkish FMF children carrying E148Q mutation.

Authors:  Fatma Aydın; Nilgün Çakar; Zeynep Birsin Özçakar; Nermin Uncu; Özge Başaran; Semanur Özdel; Elif Çelikel; Atilla H Elhan; Fatoş Yalçınkaya
Journal:  J Clin Lab Anal       Date:  2019-02-04       Impact factor: 2.352

4.  Frequencies of the MEFV Gene Mutations in Azerbaijan.

Authors:  L S Huseynova; S N Mammadova; Kaa Aliyeva
Journal:  Balkan J Med Genet       Date:  2022-06-05       Impact factor: 0.810

5.  Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome.

Authors:  Zhanna A Ktsoyan; Natalia V Beloborodova; Anahit M Sedrakyan; George A Osipov; Zaruhi A Khachatryan; Gayane P Manukyan; Karine A Arakelova; Alvard I Hovhannisyan; Arsen A Arakelyan; Karine A Ghazaryan; Magdalina K Zakaryan; Rustam I Aminov
Journal:  Front Cell Infect Microbiol       Date:  2013-01-28       Impact factor: 5.293

Review 6.  From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases.

Authors:  Donato Rigante; Bruno Frediani; Mauro Galeazzi; Luca Cantarini
Journal:  Biomed Res Int       Date:  2013-07-23       Impact factor: 3.411

7.  Primary Immunodeficiencies in Russia: Data From the National Registry.

Authors:  Anna A Mukhina; Natalya B Kuzmenko; Yulia A Rodina; Irina V Kondratenko; Andrei A Bologov; Tatiana V Latysheva; Andrei P Prodeus; Alexander N Pampura; Dmitrii N Balashov; Natalya I Ilyina; Elena A Latysheva; Ekaterina A Deordieva; Oksana A Shvets; Elena V Deripapa; Irina N Abramova; Olga E Pashenko; Svetlana S Vahlyarskaya; Natalya V Zinovyeva; Sergei B Zimin; Elena V Skorobogatova; Elena B Machneva; Daria S Fomina; Maria G Ipatova; Ludmila Yu Barycheva; Ludmila S Khachirova; Irina A Tuzankina; Michail A Bolkov; Natalya V Shakhova; Elena M Kamaltynova; Farida I Sibgatullina; Marina N Guseva; Raisa N Kuznetsova; Anzhelika M Milichkina; Areg A Totolian; Natalia M Kalinina; Evgenia A Goltsman; Ekatherina I Sulima; Anastasia Yu Kutlyanceva; Anna A Moiseeva; Anna L Khoreva; Zoya Nesterenko; Elena V Tymofeeva; A Ermakova; Dilyara D Proligina; Linara R Kalmetieva; Gulshat A Davletbaieva; Irina A Mirsayapova; Olga A Richkova; Ksenia P Kuzmicheva; Maria A Grakhova; Natalya B Yudina; Ekaterina A Orlova; Olga S Selezneva; Svetlana G Piskunova; Tatiana V Samofalova; Tatiana V Bukina; Anna D Pechkurova; N Migacheva; A Zhestkov; Elena V Barmina; Natalya A Parfenova; Svetlana N Isakova; Elena V Averina; Irina V Sazonova; Svetlana Yu Starikova; Tatiana V Shilova; Tatiana V Asekretova; Roman N Suprun; Elena I Kleshchenko; Vladimir V Lebedev; Elena V Demikhova; Valerii G Demikhov; Veronica A Kalinkina; Alla V Gorenkova; Svetlana N Duryagina; Tatiana B Pavlova; Vera M Shinkareva; Irina V Smoleva; Tatiana P Aleksandrova; Zema V Bambaeva; Marina A Philippova; Elena M Gracheva; Galina I Tcyvkina; Alexey V Efremenkov; D Mashkovskaya; Irina V Yarovaya; Valentina A Alekseenko; Ivan V Fisyun; Galina V Molokova; Ekatherina V Troitskya; Ludmila I Piatkina; Elena V Vlasova; O Ukhanova; Ekaterina G Chernishova; M Vasilieva; Olga M Laba; E Volodina; Ekaterina V Safonova; Kirill A Voronin; Maria V Gurkina; Alexander G Rumyantsev; Galina A Novichkova; Anna Yu Shcherbina
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

8.  Genome sequencing unveils mutational landscape of the familial Mediterranean fever: Potential implications of IL33/ST2 signalling.

Authors:  Meenakshi Umar; Andre Megarbane; Jingxuan Shan; Najeeb Syed; Eliane Chouery; Elbay Aliyev; Puthen Jithesh; Ramzi Temanni; Issam Mansour; Lotfi Chouchane; Aouatef Ismail Chouchane
Journal:  J Cell Mol Med       Date:  2020-08-27       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.